Interestingly, the levels of GSK3B are significantly upregulated in human pancreatic cancer patients, and this upregulation is closely associated with a decrease in overall survival (TCGA database; http://gepia.cancer-pku.cn). This evidence concerns the gene GSK3B and familial pancreatic carcinoma.